These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1063 related articles for article (PubMed ID: 32937817)
1. Characterization and Evaluation of Bone-Derived Nanoparticles as a Novel pH-Responsive Carrier for Delivery of Doxorubicin into Breast Cancer Cells. Haque ST; Islam RA; Gan SH; Chowdhury EH Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937817 [No Abstract] [Full Text] [Related]
2. Fe/Mg-Modified Carbonate Apatite with Uniform Particle Size and Unique Transport Protein-Related Protein Corona Efficiently Delivers Doxorubicin into Breast Cancer Cells. Haque ST; Karim ME; Abidin SAZ; Othman I; Holl MMB; Chowdhury EH Nanomaterials (Basel); 2020 Apr; 10(5):. PubMed ID: 32349272 [TBL] [Abstract][Full Text] [Related]
3. Modified methods of nanoparticles synthesis in pH-sensitive nano-carriers production for doxorubicin delivery on MCF-7 breast cancer cell line. Hamidu A; Mokrish A; Mansor R; Razak ISA; Danmaigoro A; Jaji AZ; Bakar ZA Int J Nanomedicine; 2019; 14():3615-3627. PubMed ID: 31190815 [No Abstract] [Full Text] [Related]
4. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer. Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060 [TBL] [Abstract][Full Text] [Related]
5. Facile strategy by hyaluronic acid functional carbon dot-doxorubicin nanoparticles for CD44 targeted drug delivery and enhanced breast cancer therapy. Li J; Li M; Tian L; Qiu Y; Yu Q; Wang X; Guo R; He Q Int J Pharm; 2020 Mar; 578():119122. PubMed ID: 32035259 [TBL] [Abstract][Full Text] [Related]
6. Facile preparation of a pH-sensitive biocompatible nanocarrier based on magnetic layered double hydroxides/Cu MOFs-chitosan crosslinked к-carrageenan for controlled doxorubicin delivery to breast cancer cells. Taghikhani A; Babazadeh M; Davaran S; Ghasemi E Colloids Surf B Biointerfaces; 2024 Nov; 243():114122. PubMed ID: 39079184 [TBL] [Abstract][Full Text] [Related]
7. Stepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicin. Chen WL; Li F; Tang Y; Yang SD; Li JZ; Yuan ZQ; Liu Y; Zhou XF; Liu C; Zhang XN Int J Nanomedicine; 2017; 12():4241-4256. PubMed ID: 28652730 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of a novel biocompatible magnetic nanomedicine based on beta-cyclodextrin, loaded doxorubicin-curcumin for overcoming chemoresistance in breast cancer. Rastegar R; Akbari Javar H; Khoobi M; Dehghan Kelishadi P; Hossein Yousefi G; Doosti M; Hossien Ghahremani M; Shariftabrizi A; Imanparast F; Gholibeglu E; Gholami M Artif Cells Nanomed Biotechnol; 2018; 46(sup2):207-216. PubMed ID: 29688063 [TBL] [Abstract][Full Text] [Related]
10. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy. Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810 [TBL] [Abstract][Full Text] [Related]
11. Increased Toxicity of Doxorubicin Encapsulated into pH-Responsive Poly(β-Amino Ester)-Functionalized MCM-41 Silica Nanoparticles. Ávila-Ortega A; Carrillo-Cocom LM; Olán-Noverola CE; Nic-Can GI; Vilchis-Nestor AR; Talavera-Pech WA Curr Drug Deliv; 2020; 17(9):799-805. PubMed ID: 32723272 [TBL] [Abstract][Full Text] [Related]
12. The tumor accumulation and therapeutic efficacy of doxorubicin carried in calcium phosphate-reinforced polymer nanoparticles. Min KH; Lee HJ; Kim K; Kwon IC; Jeong SY; Lee SC Biomaterials; 2012 Aug; 33(23):5788-97. PubMed ID: 22591612 [TBL] [Abstract][Full Text] [Related]
13. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system. Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835 [TBL] [Abstract][Full Text] [Related]
14. Doxorubicin-Loaded Carbon Dots Lipid-Coated Calcium Phosphate Nanoparticles for Visual Targeted Delivery and Therapy of Tumor. Zhang J; Zhang H; Jiang J; Cui N; Xue X; Wang T; Wang X; He Y; Wang D Int J Nanomedicine; 2020; 15():433-444. PubMed ID: 32021189 [TBL] [Abstract][Full Text] [Related]
15. A smart tumor targeting peptide-drug conjugate, pHLIP-SS-DOX: synthesis and cellular uptake on MCF-7 and MCF-7/Adr cells. Song Q; Chuan X; Chen B; He B; Zhang H; Dai W; Wang X; Zhang Q Drug Deliv; 2016 Jun; 23(5):1734-46. PubMed ID: 25853477 [TBL] [Abstract][Full Text] [Related]
16. Designed Synthesis of Lipid-Coated Polyacrylic Acid/Calcium Phosphate Nanoparticles as Dual pH-Responsive Drug-Delivery Vehicles for Cancer Chemotherapy. Wang X; Zhang M; Zhang L; Li L; Li S; Wang C; Su Z; Yuan Y; Pan W Chemistry; 2017 May; 23(27):6586-6595. PubMed ID: 28218434 [TBL] [Abstract][Full Text] [Related]
17. Preparation of pH-responsive mesoporous hydroxyapatite nanoparticles for intracellular controlled release of an anticancer drug. Li D; Huang X; Wu Y; Li J; Cheng W; He J; Tian H; Huang Y Biomater Sci; 2016 Feb; 4(2):272-80. PubMed ID: 26484364 [TBL] [Abstract][Full Text] [Related]
18. Enzyme and Thermal Dual Responsive Amphiphilic Polymer Core-Shell Nanoparticle for Doxorubicin Delivery to Cancer Cells. Kashyap S; Singh N; Surnar B; Jayakannan M Biomacromolecules; 2016 Jan; 17(1):384-98. PubMed ID: 26652038 [TBL] [Abstract][Full Text] [Related]
19. A new combination strategy to enhance apoptosis in cancer cells by using nanoparticles as biocompatible drug delivery carriers. Kucuksayan E; Bozkurt F; Yilmaz MT; Sircan-Kucuksayan A; Hanikoglu A; Ozben T Sci Rep; 2021 Jun; 11(1):13027. PubMed ID: 34158544 [TBL] [Abstract][Full Text] [Related]
20. A pH-responsive glycolipid-like nanocarrier for optimising the time-dependent distribution of free chemical drugs in focal cells. Cheng B; Lu B; Liu X; Meng T; Tan Y; Zhu Y; Liu N; Yuan H; Huang X; Hu F Int J Pharm; 2017 Apr; 522(1-2):210-221. PubMed ID: 28259679 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]